expert roundtables by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Improving the ability to gauge seizure risk and to forecast seizures for individuals with epilepsy is an unmet need and a growing area of research.......READ MORE
clinical topic updates by James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Some studies indicate that the newer antiepileptic drugs (AEDs) do not interfere with learning, while others have found an association between some......READ MORE
Neurostimulation is receiving increasing attention, with growing recognition of the great potential to intervene on the brain networks involved in ......READ MORE
expert roundtables by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Treatment options for patients with drug-resistant focal epilepsy who are not eligible for surgical resection include devices such as deep brain st......READ MORE
expert roundtables by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Advances with regard to the newer antiepileptic drugs (AEDs) include fewer side effects and more forgiving therapeutic windows. Our featured expert......READ MORE
Patient resilience is a key factor in quality of life among individuals with epilepsy. Even among patients with intractable seizures, having a good......READ MORE
